Amj Wensing

Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)

Maurizio Zazzi, Rolf Kaiser, Anders Sönnerborg et al. · HIV Medicine · 2010 · 49 citations · Full text

Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid

S.F.L. van Lelyveld, Monique Nijhuis, Franky Baatz et al. · Clinical Infectious Diseases · 2010 · 30 citations · Full text

Immunology, Antiviral Drug, Therapy Failure +16

Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient

Jori Symons, S.F.L. van Lelyveld, A. I. M. Hoepelman et al. · Journal of Antimicrobial Chemotherapy · 2011 · 29 citations · Full text

Consensus statement of the European guidelines on clinical management of HIV‐1 tropism testing

Amj Wensing, Rolf Kaiser, F. Brun-Vézinet et al. · Journal of the International AIDS Society · 2010 · 18 citations · Full text

European Guidelines, Pharmacotherapy, Antiviral Drug +16

Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study

Amj Wensing, David van de Vijver, B Asjo et al. · Antiviral Therapy · 2003 · 15 citations

Non-b Sequences, Drug Resistance Analysis, Transmitted Drug Resistance +11